Rare Disease Stakeholders: Do mRNA COV19 Vaccines Affect Eligibility to Receive Future Gene Therapy?

The American Society of Gene and Cell Therapy issued FAQs on December 30, 2020 to explain how mRNA vaccines for COVID19 work and why they are safe and effective. One of the key questions that people with rare diseases may ask is whether receiving an mRNA vaccine could impact an individual's eligibility to receive a gene therapy for their rare disease in the future. ASCGT's scientific experts answer is clear: because there is not use of a virus or viral vector with the mRNA vaccines, receiving an mRNA vaccine will not preclude an individual from obtaining a gene therapy in the future for a rare disease. Of course If someone is immunocompromised, they should speak with their provider to make the decision about getting vaccinate. Read the FAQs here